These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36267362)

  • 21. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
    Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' disease.
    Yasuda K; Miyoshi Y; Tachibana M; Namba N; Miki K; Nakata Y; Takano T; Ozono K
    Clin Pediatr Endocrinol; 2017 Jan; 26(1):1-7. PubMed ID: 28203042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
    Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
    Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
    Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term methimazole therapy in Graves' hyperthyroidism and adverse reactions: a Danish multicenter study.
    Karmisholt J; Andersen SL; Bulow-Pedersen I; Krejbjerg A; Nygaard B; Carlé A
    Eur Thyroid J; 2022 May; 11(3):. PubMed ID: 35521775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations and early effectiveness of methimazole in patients with graves' hyperthyroidism-related severe hepatic dysfunction.
    Li C; Wang KL; Hu JH; Su HB
    Scand J Gastroenterol; 2023; 58(12):1514-1522. PubMed ID: 37545358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves' Disease Hyperthyroidism During Methimazole Treatment.
    Gallo D; Mortara L; Veronesi G; Cattaneo SA; Genoni A; Gallazzi M; Peruzzo C; Lasalvia P; Moretto P; Bruno A; Passi A; Pini A; Nauti A; Lavizzari MA; Marinò M; Lanzolla G; Tanda ML; Bartalena L; Piantanida E
    Front Endocrinol (Lausanne); 2022; 13():886451. PubMed ID: 35784564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THERAPEUTIC EFFECTS OF COMBINATION REGIMENS INCLUDING METHIMAZOLE ON GRAVES HYPERTHYROIDISM: A NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.
    Wang M; Yu Y
    Endocr Pract; 2020 Jun; 26(6):675-687. PubMed ID: 32160045
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term maintenance of low-dose antithyroid drugs versus drug withdrawal in patients with Graves' hyperthyroidism.
    Morales García F; Cayuela A; García Hernández N; Losada Viñau F; Mangas Cruz MÁ; Martínez Brocca MA; Navarro González E; Pumar López A; Relimpio Astolfi F; Soto Moreno A; Villamil Fernández F
    Endocrinol Nutr; 2008 Mar; 55(3):123-31. PubMed ID: 22967878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
    Saadat N; Azizi F; Abdi H; Amouzegar A
    J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism.
    Okamura K; Ikenoue H; Shiroozu A; Sato K; Yoshinari M; Fujishima M
    J Clin Endocrinol Metab; 1987 Oct; 65(4):719-23. PubMed ID: 3654917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A patient-specific treatment model for Graves' hyperthyroidism.
    Pandiyan B; Merrill SJ; Di Bari F; Antonelli A; Benvenga S
    Theor Biol Med Model; 2018 Jan; 15(1):1. PubMed ID: 29310665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Application of Quantitative Single-Photon Emission Computed Tomography/Computed Tomography to Predict Early Response to Methimazole in Graves' Disease.
    Kim HJ; Bang JI; Kim JY; Moon JH; So Y; Lee WW
    Korean J Radiol; 2017; 18(3):543-550. PubMed ID: 28458607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of relapse of Graves' disease by treatment with an intrathyroid injection of dexamethasone.
    Mao XM; Li HQ; Li Q; Li DM; Xie XJ; Yin GP; Zhang P; Xu XH; Wu JD; Chen SW; Wang SK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4984-91. PubMed ID: 19850691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Subclinical Hyperthyroidism in the Elderly: Comparison of Radioiodine and Long-Term Methimazole Treatment.
    Azizi F; Abdi H; Cheraghi L; Amouzegar A
    Thyroid; 2021 Apr; 31(4):545-551. PubMed ID: 32811342
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
    Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
    Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial.
    Bonnema SJ; Bennedbaek FN; Gram J; Veje A; Marving J; Hegedus L
    Eur J Endocrinol; 2003 Dec; 149(6):485-92. PubMed ID: 14640988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug.
    Gheorghiu ML; Bors RG; Gheorghisan-Galateanu AA; Pop AL; Cretoiu D; Varlas VN
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.